WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006115987) USE OF A CLOBETASOL SPRAY FORMULATION TO TREAT PSORIASIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/115987    International Application No.:    PCT/US2006/014903
Publication Date: 02.11.2006 International Filing Date: 20.04.2006
IPC:
A61K 31/56 (2006.01), A61L 9/04 (2006.01)
Applicants: DOW PHARMACEUTICAL SCIENCES [US/US]; 1330 A Redwood Way, Petaluma, California 94954-6542 (US) (For All Designated States Except US).
DOW, Gordon, J. [US/US]; (US) (For US Only).
STEWART, Daniel, M. [US/US]; (US) (For US Only).
DERMALOGIX PARTNERS, INC.; 672 US Route 1, PO Box 1510, Scarborough, ME 04070
Inventors: DOW, Gordon, J.; (US).
STEWART, Daniel, M.; (US)
Agent: EISENBERG, Howard; 1220 Limberlost Lane, Gladwyne, Pennsylvania 19035 (US)
Priority Data:
60/674,946 25.04.2005 US
Title (EN) USE OF A CLOBETASOL SPRAY FORMULATION TO TREAT PSORIASIS
(FR) UTILISATION D'UNE FORMULATION PULVERISABLE AU CLOBETASOL POUR TRAITER LE PSORIASIS
Abstract: front page image
(EN)The present invention provides a method for treating psoriasis, by spraying onto the skin with psoriasis daily for at least 4 weeks a pharmaceutical composition containing an effective amount of clobetasol propionate. A preferred pharmaceutical composition containing clobetasol propionate, ethyl alcohol, isopropyl myristate, and anionic surfactant.
(FR)L'invention concerne un procédé pour traiter le psoriasis en pulvérisant sur la peau atteinte de psoriasis, chaque jour pendant au moins 4 semaines, une composition pharmaceutique contenant une quantité efficace de propionate de clobétasol. L'invention concerne également une composition pharmaceutique préférée contenant du propionate de clobétasol, de l'alcool éthylique, du myristate d'isopropyle et un tensioactif anionique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)